Verily, Kyverna Therapeutics forge collaboration for autoimmune research
Verily, an Alphabet precision health technology company, and Kyverna Therapeutics, a clinical-stage cell therapy company, have announced a multi-year collaboration. The initial focus is on ... Read More
Verily partners with OneOncology: Next-gen SignalPath platform to revolutionize clinical trials in oncology
In a groundbreaking collaboration that promises to reshape the landscape of oncology clinical trials, Alphabet's precision health tech subsidiary, Verily, is teaming up with OneOncology, ... Read More